Yahoo! Inc. (YHOO) Among Billionaire James Dinan’s New Stock Picks

YORK CAPITAL MANAGEMENTJames Dinan founded York Capital in 1991 and now has a net worth estimated at $1.4 billion. In November the fund filed its 13F for the third quarter of 2012, disclosing many of its long equity positions as of the end of September (see the full list of stocks form the 13F). This is the most complete information that market watchers get about hedge fund moves, though it comes months after the fund began making the trades disclosed in the filing. We have compared the document to York’s filing for the end of June and here are the five largest new positions by market value for the third quarter of the year:

Dinan and his team liked Yahoo! Inc. (NASDAQ:YHOO), initiating a position of 11.4 million shares. Yahoo seems to have been a popular pick among hedge funds during the quarter; fellow billionaire David Einhorn, for example, also added Yahoo to his portfolio (find more of billionaire David Einhorn’s stock picks). We’re a bit more cautious; the media seems overeager to anoint new CEO Marissa Mayer as the company’s savior, and we’re worried that management will be tempted to engage in some attention-getting but unproductive strategic initiative rather than focus on the core business. In addition, Yahoo trades at 16 times forward earnings estimates- this is actually a small premium to Google’s forward P/E.

York also liked General Growth Properties Inc (NYSE:GGP), which is notable for being one of Pershing Square’s top picks; that fund, managed by billionaire Bill Ackman, reported owning $1.5 billion in GGP stock at the end of September (check out more of Pershing Square’s top stock holdings). General Growth Properties is a real estate investment trust which is focused on shopping malls primarily in the United States. Because the prospects of the mall business are tied to brick-and-mortar retail sales, the stock is exposed to the broader economy and carries a beta of 2.

Dun & Bradstreet Corp (NYSE:DNB) was another of the fund’s largest new stock picks. Dun & Bradstreet is a $3.6 billion market cap company whose services include risk management, marketing data, and business information. Its earnings were up 36% in the third quarter compared to the same period in 2011, though revenue slipped 6%, and in valuation terms it looks good at 13 times trailing earnings. We’re interested in the company as a potential value play, but we would note that the most recent data shows 11% of the shares outstanding held short.

The fund initiated a position of 6.2 million shares in MetroPCS Communications Inc (NYSE:PCS), which is well liked by Wall Street analysts given the fact that their earnings projections imply a forward P/E multiple of 13 and a five-year PEG ratio of 0.7. However, as with Dun & Bradstreet there’s considerable short interest here suggesting that a number of traders are much more pessimistic on the company. While the stock appears cheaper than that of leading peers like Verizon, the difference appears small in terms of forward earnings estimates and we’re not sure that the company is that much better a value.

York was apparently one of the funds which believed that Chinese oil company CNOOC’s purchase of Nexen Inc. (NYSE:NXY) would be approved by the Canadian government, as it also bought shares of Nexen between July and September. CNOOC’s offer is a heavy premium to where the stock had previously been trading, so the fund stands to see significant losses if the deal is rejected (it is controversial in Canada, and the government has already pushed back a date to announce its decision). Nexen is best known for its position the Alberta tar sands, a leading prospect for unconventional oil production. We don’t feel confident enough in the transaction going through to recommend the stock, but it certainly provides a potential profit if an investor decides that Canada will allow a deal to happen.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!